• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名年轻韩国女性接种BNT162b2新冠mRNA疫苗后因动静脉畸形潜在破裂导致颅内出血:病例报告

Intracranial Hemorrhage Due to Potential Rupture of an Arteriovenous Malformation after BNT162b2 COVID-19 mRNA Vaccination in a Young Korean Woman: Case Report.

作者信息

Kim Byoung Hoon, Yoo Myung Chul

机构信息

Department of Physical Medicine & Rehabilitation, College of Medicine, Kyung Hee University Hospital, 23 Kyung Hee Dae-ro, Dongdaemun-gu, Seoul 02447, Korea.

出版信息

Vaccines (Basel). 2022 Feb 25;10(3):362. doi: 10.3390/vaccines10030362.

DOI:10.3390/vaccines10030362
PMID:35334996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8953327/
Abstract

Inoculation with the Pfizer-BioNTech coronavirus infection-19 (COVID-19) vaccine (BNT162b2) has been approved in Korea. Although it is generally safe, several possible side effects have been reported. The present report describes a 28-year-old woman who developed an intracerebral hemorrhage in her right temporal lobe after the first dose of the Pfizer-BioNTech COVID-19 vaccine. The patient complained of a persistent headache for four days after the first dose, along with right third nerve palsy and drowsiness. Non-enhanced brain computed tomography confirmed a 5.0 × 3.7 × 5.0 cm-sized intracranial hemorrhage in the right temporal lobe due to the rupture of an arteriovenous malformation (AVM). Transfemoral cerebral angiography revealed that blood was supplied to the AVM by the right middle cerebral artery branch and drained into the right transverse sinus. The patient underwent surgical treatment for AVM nidus removal with hematoma evacuation on the day of admission. Her condition stabilized 10 days postoperatively. These findings indicate that clinicians should be aware that cerebral hemorrhage caused by AVM rupture may be a side effect of inoculation with the BNT162b2 mRNA COVID-19 vaccine.

摘要

辉瑞 - 生物科技公司的冠状病毒感染19(COVID - 19)疫苗(BNT162b2)接种已在韩国获得批准。尽管该疫苗总体上是安全的,但已有一些可能的副作用报告。本报告描述了一名28岁女性,在接种第一剂辉瑞 - 生物科技公司COVID - 19疫苗后,右侧颞叶发生脑出血。患者在接种第一剂疫苗后持续头痛四天,伴有右侧动眼神经麻痹和嗜睡。脑部非增强计算机断层扫描证实,由于动静脉畸形(AVM)破裂,右侧颞叶有一个5.0×3.7×5.0厘米大小的颅内出血。经股动脉脑血管造影显示,AVM由右侧大脑中动脉分支供血,并引流至右侧横窦。患者在入院当天接受了手术治疗,切除AVM病灶并清除血肿。术后10天她的病情稳定。这些发现表明,临床医生应意识到,AVM破裂导致的脑出血可能是接种BNT162b2 mRNA COVID - 19疫苗的一种副作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9481/8953327/c245250fcc6a/vaccines-10-00362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9481/8953327/c245250fcc6a/vaccines-10-00362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9481/8953327/c245250fcc6a/vaccines-10-00362-g001.jpg

相似文献

1
Intracranial Hemorrhage Due to Potential Rupture of an Arteriovenous Malformation after BNT162b2 COVID-19 mRNA Vaccination in a Young Korean Woman: Case Report.一名年轻韩国女性接种BNT162b2新冠mRNA疫苗后因动静脉畸形潜在破裂导致颅内出血:病例报告
Vaccines (Basel). 2022 Feb 25;10(3):362. doi: 10.3390/vaccines10030362.
2
Intracranial Hemorrhage After Pfizer-BioNTech (BNT162b2) mRNA COVID-19 Vaccination: A Case Report.辉瑞-生物科技(BNT162b2)mRNA新冠疫苗接种后颅内出血:一例报告
Cureus. 2023 Apr 18;15(4):e37747. doi: 10.7759/cureus.37747. eCollection 2023 Apr.
3
Acute rupture of a feeding artery aneurysm after embolization of a brain arteriovenous malformation.脑动静脉畸形栓塞术后供血动脉动脉瘤急性破裂。
Interv Neuroradiol. 2015 Oct;21(5):613-9. doi: 10.1177/1591019915591740. Epub 2015 Jun 30.
4
Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.健康女性在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后发生广泛脑静脉窦血栓形成(CVST),但无血栓性血小板减少综合征(TTS)。
Am J Case Rep. 2022 Feb 9;23:e934744. doi: 10.12659/AJCR.934744.
5
Rupture of Vertebral Artery Dissecting Aneurysm after mRNA Anti-COVID-19 Vaccination: A Report of Two Cases.mRNA 新冠疫苗接种后椎动脉夹层动脉瘤破裂:两例报告
NMC Case Rep J. 2022 Apr 28;9:95-100. doi: 10.2176/jns-nmc.2022-0012. eCollection 2022.
6
Spontaneous subdural hematoma concomitant with subarachnoid hemorrhage and intracerebral hemorrhage due to ruptured brain arteriovenous malformation treated with curative embolization.因脑动静脉畸形破裂导致的自发性硬膜下血肿合并蛛网膜下腔出血和脑出血,采用根治性栓塞治疗。
J Neurosci Rural Pract. 2023 Apr-Jun;14(2):368-370. doi: 10.25259/JNRP_13_2023. Epub 2023 Apr 5.
7
[Tentorial dural arteriovenous malformation--a case report (author's transl)].小脑幕硬脑膜动静脉畸形——病例报告(作者译)
No Shinkei Geka. 1976 Dec;4(12):1185-91.
8
Ruptured tectal arteriovenous malformation demonstrated angiographically after removal of an unruptured occipital lobe arteriovenous malformation.在切除未破裂的枕叶动静脉畸形后,血管造影显示中脑顶盖动静脉畸形破裂。
Neurol Med Chir (Tokyo). 2009 Jan;49(1):30-2. doi: 10.2176/nmc.49.30.
9
[A case of cerebral arteriovenous malformation complicated with intracerebral hemorrhage after endovascular embolization].1例脑动静脉畸形血管内栓塞术后并发脑出血
No Shinkei Geka. 2001 Apr;29(4):353-8.
10
Intracranial pial arteriovenous fistula presenting with hemorrhage: a case report.颅内软膜动静脉瘘伴出血:一例报告。
J Cerebrovasc Endovasc Neurosurg. 2012 Dec;14(4):305-8. doi: 10.7461/jcen.2012.14.4.305. Epub 2012 Dec 29.

引用本文的文献

1
Nationwide Cohort observational study on the safety and efficacy of COVID-19 vaccination in patients with Moyamoya disease.一项关于 COVID-19 疫苗在烟雾病患者中安全性和有效性的全国性队列观察性研究。
Sci Rep. 2024 Oct 17;14(1):24400. doi: 10.1038/s41598-024-73940-5.
2
Central nervous system manifestations following vaccination against COVID-19.接种新型冠状病毒疫苗后的中枢神经系统表现。
Brain Behav Immun Health. 2024 May 3;38:100788. doi: 10.1016/j.bbih.2024.100788. eCollection 2024 Jul.
3
Intracranial Hemorrhage After Pfizer-BioNTech (BNT162b2) mRNA COVID-19 Vaccination: A Case Report.

本文引用的文献

1
Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?新冠病毒mRNA疫苗接种后儿童自身抗体的释放:多系统炎症综合征的一个危险因素?
Vaccines (Basel). 2021 Nov 18;9(11):1353. doi: 10.3390/vaccines9111353.
2
BNT162b2 and ChAdOx1 SARS-CoV-2 Post-vaccination Side-Effects Among Saudi Vaccinees.沙特疫苗接种者中BNT162b2和ChAdOx1新冠疫苗接种后的副作用
Front Med (Lausanne). 2021 Oct 8;8:760047. doi: 10.3389/fmed.2021.760047. eCollection 2021.
3
COVID-19 outbreak as a probable cause of increased risk of intracranial rebleeding in partially treated cerebral arteriovenous malformations.
辉瑞-生物科技(BNT162b2)mRNA新冠疫苗接种后颅内出血:一例报告
Cureus. 2023 Apr 18;15(4):e37747. doi: 10.7759/cureus.37747. eCollection 2023 Apr.
新冠疫情可能是部分治疗的脑动静脉畸形患者颅内再出血风险增加的原因。
Clin Case Rep. 2021 Oct 4;9(10):e04893. doi: 10.1002/ccr3.4893. eCollection 2021 Oct.
4
mRNA vaccines for infectious diseases: principles, delivery and clinical translation.传染病的 mRNA 疫苗:原理、传递和临床转化。
Nat Rev Drug Discov. 2021 Nov;20(11):817-838. doi: 10.1038/s41573-021-00283-5. Epub 2021 Aug 25.
5
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen(强生)和 mRNA COVID-19 疫苗(辉瑞-生物科技和莫德纳)成年受种者发生不良事件后使用 COVID-19 疫苗:免疫实践咨询委员会的更新-美国,2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.
6
Myocarditis With COVID-19 mRNA Vaccines.COVID-19 mRNA 疫苗相关心肌炎。
Circulation. 2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul 20.
7
Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis.类风湿关节炎患者使用抗SARS-CoV-2 mRNA疫苗。
Lancet Rheumatol. 2021 Jul;3(7):e470-e472. doi: 10.1016/S2665-9913(21)00186-7. Epub 2021 Jun 8.
8
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech).在接受托珠单抗(BNT162b2,辉瑞-生物科技公司)的日本女性中可能出现的不良事件。
J Pharm Policy Pract. 2021 May 31;14(1):46. doi: 10.1186/s40545-021-00326-7.
9
SARS-CoV-2 vaccines are not free of neurological side effects.新型冠状病毒2型疫苗并非没有神经方面的副作用。
Acta Neurol Scand. 2021 Jul;144(1):109-110. doi: 10.1111/ane.13451. Epub 2021 May 17.
10
COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room.新冠病毒疫苗的效力和效果——房间里的(并非)大象。
Lancet Microbe. 2021 Jul;2(7):e279-e280. doi: 10.1016/S2666-5247(21)00069-0. Epub 2021 Apr 20.